176 related articles for article (PubMed ID: 1465837)
1. Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
[No Abstract] [Full Text] [Related]
2. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
[No Abstract] [Full Text] [Related]
3. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
4. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
5. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
[No Abstract] [Full Text] [Related]
6. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
7. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
8. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
[No Abstract] [Full Text] [Related]
9. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
10. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
Leivestad T; Berger L; Thorsby E
Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
[No Abstract] [Full Text] [Related]
11. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
12. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
Adam K; Polymenidis Z; Papakyriazi L; Alexopoulos E; Parapanissiou E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
[No Abstract] [Full Text] [Related]
13. DR6 compatibility and kidney graft survival.
Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
[No Abstract] [Full Text] [Related]
14. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
15. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
Park K; Kim YS; Kim SI
Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
[No Abstract] [Full Text] [Related]
16. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
17. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
18. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
[No Abstract] [Full Text] [Related]
19. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.
Middleton D; Mytilineos Y; Savage D; Ferrara GB; Angelini G; Amoroso A; Trainor F; Gaweco A; Mazzola G; Delfino L
Transplant Proc; 1992 Dec; 24(6):2439-40. PubMed ID: 1361255
[No Abstract] [Full Text] [Related]
20. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
